4D in the news
Low-Code Development Platform
Tamtam found 9 recent articles about 4D.
- Erhan Ciris, Founder of 4D Sight
4D Sight uses AI to seamlessly integrate virtual ads into live sports and esports broadcasts, enhancing monetization without disrupting viewer experience.
- Biotech 4DMT hands 124,200 stock units to just nine recruits
4D Molecular Therapeutics awarded 124,200 RSUs to nine new employees to attract talent under its 2025 inducement plan.
- RBC Capital maintient sa note Surperformance sur l’action 4D Molecular à 32$
4D Molecular Therapeutics is advancing retinal disease treatments with strong clinical progress, a major partnership with Otsuka, and is viewed as undervalued by analysts.
- Certain Options of 4D Molecular Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 6-JAN-2026.
Certain stock options of 4D Molecular Therapeutics are under a lock-up agreement until January 6, 2026, restricting sales by executives and directors.
- Ashoo Gupta of 4D Molecular Therapeutics sells $3.3k in FDMT stock
4D Molecular Therapeutics appointed a new CFO, secured a major licensing deal with Otsuka, and saw stock upgrades and price target increases following positive clinical and financial developments.
- 4D Molecular posts Phase 1 trial data for cystic fibrosis drug
4D Molecular Therapeutics shared updated Phase 1 data for its cystic fibrosis drug 4D-710, leading to a 15% stock drop.
- 4D Path Collaborates with AMD and Oracle to Scale Predictive Oncology
4D Path partners with AMD and Oracle to use CPU-based AI for scalable, explainable predictive oncology and faster clinical trials.
- 4d Molecular Therapeutics chief legal officer sells $17k in stock
4D Molecular Therapeutics' legal officer sold shares amid positive clinical results, a new CFO appointment, and a lucrative licensing deal with Otsuka Pharmaceuticals.
- Watkins Advises 4D Molecular Therapeutics on US$100 Million Offering of Common Stock and Pre-Funded Warrants
4D Molecular Therapeutics announced a $100 million stock and warrant offering priced at about $10.51 per share, closing in November 2025.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like 4D?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies